PharmaLex Group enters into collaboration with Kiana Systems

The partnership will enable the automation of summary documents using Artificial Intelligence based software

Frankfurt, Germany, September 29th 2017: As at 14th September, 2017, the PharmaLex Group, a leading specialist provider of Development Consulting, Regulatory Affairs, Quality Management & Compliance Services as well as Pharmacovigilance, has entered into collaboration with Kiana Systems, a leading provider of data science, machine learning and artificial intelligence based in Saarbrücken, Germany.

The partnership will utilize the respective expertise of both companies to develop bespoke Artificial Intelligence based software that will ultimately automate the creation of summary documents as part of the Common Technical Document (CTD) compilation. In the first instance, the software is intended to create substantial efficiencies in this process, while the use of machine learning technologies should allow full automation of the process in the long run.

“We are delighted to be working with PharmaLex on this exciting and innovative project”, explained Mathias Bauer, Managing Director & Chief Scientific Officer at Kiana Systems. “We are already working in the pharma industry to provide better access to key data”, he added. “Our partnership with Kiana Systems will enable us to provide clients with time and cost savings” explained Dr. Thomas Dobmeyer, CEO at PharmaLex. “Not only will we be able to streamline the creation of summary documentation via Artificial Intelligence led services, we also hope to offer Software as a Service (SaaS) in the future” explained Dr. Tilo Netzer, CEO at PharmaLex. “The possibilities of this partnership are endless”, he added.

The PharmaLex Group now has over 650 employees, with 25 offices in 14 countries and more than 600 satisfied clients worldwide.